Detalles de la búsqueda
1.
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist.
Clin Cancer Res
; 23(13): 3416-3427, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28069723
2.
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
Cancer Immunol Res
; 5(1): 29-41, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27923825
3.
Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.
Oncotarget
; 7(14): 18508-20, 2016 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26918344
Resultados
1 -
3
de 3
1
Próxima >
>>